{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:46Z","timestamp":1792208566741,"version":"4.4.0"},"reference-count":22,"publisher":"Japan Neurosurgical Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.2176\/jns-nmc.2026-0047","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:11:10Z","timestamp":1788905470000},"page":"695-700","source":"Crossref","is-referenced-by-count":0,"title":["Clazosentan, Endothelin-A Receptor Antagonist, Suppresses Interleukin-6 Expression in Cerebrospinal Fluid after Subarachnoid Hemorrhage"],"prefix":"10.2176","volume":"66","author":[{"given":"Toshiaki","family":"INOMO","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"OSUKA","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"IWAMI","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"ITO","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"IOKU","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"WATANABE","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Sato M, Tani E, Fujikawa H, et al. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 2000;87 (3):195-200. doi: 10.1161\/01.res.87.3.195","DOI":"10.1161\/01.RES.87.3.195"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Suzuki R, Masaoka H, Hirata Y, et al. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1992;77 (1):96-100. doi: 10.3171\/jns.1992.77.1.0096","DOI":"10.3171\/jns.1992.77.1.0096"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Gaetani P, Rodriguez y Baena R, Grignani G, et al. Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1994;57 (1):66-72. doi: 10.1136\/jnnp.57.1.66","DOI":"10.1136\/jnnp.57.1.66"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Fassbender K, Hodapp B, Rossol S, et al. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke. 2000;31 (12):2971-5. doi: 10.1161\/01.str.31.12.2971","DOI":"10.1161\/01.STR.31.12.2971"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Endo H, Hagihara Y, Kimura N, et al. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022;137 (6):1707-17. doi: 10.3171\/2022.2.jns212914","DOI":"10.3171\/2022.2.JNS212914"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39 (11):3015-21. doi: 10.1161\/strokeaha.108.519942","DOI":"10.1161\/STROKEAHA.108.519942"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Mayer SA, Bruder N, Citerio G, et al. REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2025;142 (1):98-109. doi: 10.3171\/2024.4.jns232191","DOI":"10.3171\/2024.4.JNS232191"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Peterson JW, Kwun BD, Hackett JD, et al. The role of inflammation in experimental cerebral vasospasm. J Neurosurg. 1990;72 (5):767-74. doi: 10.3171\/jns.1990.72.5.0767","DOI":"10.3171\/jns.1990.72.5.0767"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mathiesen T, Andersson B, Loftenius A, et al. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg. 1993;78 (4):562-7. doi: 10.3171\/jns.1993.78.4.0562","DOI":"10.3171\/jns.1993.78.4.0562"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Aihara Y, Kasuya H, Onda H, et al. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke. 2001;32 (1):212-7. doi: 10.1161\/01.str.32.1.212","DOI":"10.1161\/01.STR.32.1.212"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Niwa A, Osuka K, Nakura T, et al. Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage. J Neuroinflammation. 2016;13 (1):217. doi: 10.1186\/s12974-016-0675-7","DOI":"10.1186\/s12974-016-0675-7"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Schoch B, Regel JP, Wichert M, et al. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery. 2007;60 (5):828-36. doi: 10.1227\/01.neu.0000255440.21495.80","DOI":"10.1227\/01.NEU.0000255440.21495.80"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Lucke-Wold B, Dodd W, Motwani K, et al. Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasm. J Neuroinflammation. 2022;19 (1):228. doi: 10.1186\/s12974-022-02592-x","DOI":"10.1186\/s12974-022-02592-x"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Mascia L, Fedorko L, Stewart DJ, et al. Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2001;32 (5):1185-90. doi: 10.1161\/01.str.32.5.1185","DOI":"10.1161\/01.STR.32.5.1185"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Browatzki M, Schmidt J, K\u00fcbler W, et al. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells. Basic Res Cardiol. 2000;95 (2):98-105. doi: 10.1007\/s003950050170","DOI":"10.1007\/s003950050170"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Kikkawa Y, Matsuo S, Kameda K, et al. Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca (2+) sensitization after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012;32 (2):341-52. doi: 10.1038\/jcbfm.2011.132","DOI":"10.1038\/jcbfm.2011.132"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) Yao Y, Wu Q, Yuan K, et al. Bindarit attenuates neuroinflammation after subarachnoid hemorrhage by regulating the CCL2\/CCR2\/NF-\u03baB pathway. Brain Res Bull. 2025;220:111183. doi: 10.1016\/j.brainresbull.2024.111183","DOI":"10.1016\/j.brainresbull.2024.111183"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Koyama Y, Kotani M, Sawamura T, et al. Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1\/fractalkine and an increase in CCL2\/MCP-1 and CXCL1\/CINC-1. J Neuroinflammation. 2013;10:51. doi: 10.1186\/1742-2094-10-51","DOI":"10.1186\/1742-2094-10-51"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Koyama Y, Baba A, Matsuda T. Production of monocyte chemoattractant protein-1 and cytokine-induced neutrophil chemoattractant-1 in rat brain is stimulated by intracerebroventricular administration of an endothelin ETB receptor agonist. NeuroReport. 2007;18 (12):1275-9. doi: 10.1097\/WNR.0b013e32825a67f1","DOI":"10.1097\/WNR.0b013e32825a67f1"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20) Carter SL, M\u00fcller M, Manders PM, et al. Induction of the genes for CXCL9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia. 2007;55 (16):1728-39. doi: 10.1002\/glia.20587","DOI":"10.1002\/glia.20587"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Jin YH, Kang B, Kang HS, et al. Endothelin-1 contributes to the development of virus-induced demyelinating disease. J Neuroinflammation. 2020;17 (1):307. doi: 10.1186\/s12974-020-01986-z","DOI":"10.1186\/s12974-020-01986-z"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) George PM, Badiger R, Shao D, et al. Viral toll like receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension. Biochem Biophys Res Commun. 2012;426 (4):486-91. doi: 10.1016\/j.bbrc.2012.08.106","DOI":"10.1016\/j.bbrc.2012.08.106"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/66\/10\/66_2026-0047\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:37:20Z","timestamp":1792208240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/66\/10\/66_2026-0047\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2026-0047","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"article-number":"2026-0047"}}